Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute discovered in pre-clinical models that dormant prostate cancer cells found in bone tissue can be reawakened, causing metastasis to other parts of the body. ...
Tags: Prostate Cancer Cells, reawakened, preventing the spread of disease
Clinical trials investigating new uses for the anti-cancer drug Avastin have produced mixed results. When combined with standard chemotherapy, Avastin extended the survival of patients with advanced cervical cancer by nearly four months, ...
Article cites potential to save money on end-of-life care, medical imaging and new drug prices In a review article published Feb. 14 in The Lancet Oncology, Johns Hopkins experts identify three major sources of high cancer costs and argue ...
A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of ...
Tags: Healthcare, Life-Saving Drugs
Pfizer Inc. (NYSE:PFE) today announced that the randomized Phase 2 trial [PALOMA-1] of palbociclib achieved its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival ...
Tags: Health&Medicine
CROWN POINT,Ind.,Jan.23(UPI)--Noted oncologists call for a single-payer U.S.healthcare system--similar to Canada--because the current system is hurting cancer patients. Dr.Ray Drasga,a longtime community-based oncologist who founded a ...
Tags: healthcare system, oncologists, cancer
The Worldwide Innovative Network(WIN)Consortium in personalized cancer medicine is proud to announce that AstraZeneca,DKFZ and EORTC have joined the Consortium.WIN is a unique global network of leading academics,industries,payors and ...
Tags: WIN, cancer medicine, DKFZ, EORTC
Remedy Informatics,a provider of registry-based clinical informatics software for healthcare delivery and life sciences research,has been selected by the American Society of Clinical Oncology(ASCO)to provide the technology platform for the ...
Tags: Oncology, clinical informatics
Adamis Pharmaceuticals has announced an important addition to its intellectual property with receipt of a notice of allowance of patent claims supporting its cancer immunotherapy portfolio in the US. Notice of allowance is the final step ...
Tags: Cancer Immunology, Cancer, Cancer cure
For the fourth consecutive year, outcomes for patients receiving allogeneic transplants through the Blood and Marrow Transplant Program at Roswell Park Cancer Institute (RPCI) have been shown to be significantly better than would be ...
BioAlliance Pharma, an innovative Company dedicated to the development of orphan oncology, announced today that Validive (clonidine Lauriad) received a Fast Track designation from the US Food and Drug Administration (FDA) for the prevention ...
Tags: FDA, BioAlliance Pharma, disease, Validive
Sweden-based Elekta has received a contract valued more than $16m from Iraq for state-of-the-art radiation therapy equipment. The contract includes ten Elekta Synergy Platform linear accelerators (linacs) to be delivered to five Iraqi ...
Tags: TPS, MOSAIQ, Elekta, radiation therapy equipment
Etoposide plus cisplatin, given alongside accelerated hyperfractionated thoracic radiotherapy (AHTRT), remains the gold standard regimen for patients with limited-stage small-cell lung cancer (SCLC), Japanese researchers say. The phase ...
Agenus Inc. (Nasdaq: AGEN), a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, announced that Phase 2 results of Prophage G-200 vaccine in recurrent patients with glioblastoma ...
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Takeda Pharmaceutical's new drug application (NDA) of Adcetris (brentuximab vedotin) 50mg intended to treat patients with CD30 positive relapsed or refractory hodgkin ...